找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Breast Diseases; Ismail Jatoi,Achim Rody Book 2016Latest edition Springer International Publishing Switzerland 2016 Breast I

[復(fù)制鏈接]
樓主: 自治
31#
發(fā)表于 2025-3-27 00:08:40 | 只看該作者
32#
發(fā)表于 2025-3-27 02:49:14 | 只看該作者
33#
發(fā)表于 2025-3-27 08:28:39 | 只看該作者
Surgical Considerations in the Management of Primary Invasive Breast Cancer,tomy (CPM), and breast-conserving surgery (BCS). Following BCS, radiation therapy (RT) is often required to reduce the risk of ipsilateral breast tumor recurrence, although older patients with indolent tumors may not require radiotherapy after BCS. Moreover, radiotherapy is required for selected hig
34#
發(fā)表于 2025-3-27 09:26:46 | 只看該作者
Management of the Axilla,nd accepted as standard of care worldwide. Dual localization methods with blue dye and radioisotope are associated with optimal performance parameters such as shorter learning curve, higher identification rates and low false-negative rates. Several issues relating to surgical technique and choice of
35#
發(fā)表于 2025-3-27 16:31:24 | 只看該作者
Breast Reconstructive Surgery,mmetrical breast mound after mastectomy. Breast reconstruction can be at the time of mastectomy or as a delayed procedure. Options for reconstruction include prosthetic implants, autologous tissue, or both. Implant reconstruction is a relatively simple and effective method of breast reconstruction,
36#
發(fā)表于 2025-3-27 20:43:08 | 只看該作者
The Role of Radiotherapy in Breast Cancer Management, recurrent carcinoma of the breast. Despite the technical limitations of the early equipment, tumor shrinkage and at times complete elimination of the tumor were noticed. However, the full potential of radiation therapy could not be achieved in those early days because of the limited knowledge regar
37#
發(fā)表于 2025-3-28 01:04:14 | 只看該作者
38#
發(fā)表于 2025-3-28 04:39:19 | 只看該作者
Endocrine Therapy,ausal women, tamoxifen is the standard in low-risk patients, providing a significant reduction in both risk of recurrence and BC mortality; the addition of ovarian function suppression (OFS) to tamoxifen or the aromatase inhibitor (AI) Exemestane is recommended in patients at higher risk of relapse.
39#
發(fā)表于 2025-3-28 07:04:14 | 只看該作者
40#
發(fā)表于 2025-3-28 13:46:58 | 只看該作者
http://image.papertrans.cn/m/image/622451.jpg
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 17:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
凌源市| 大竹县| 吉隆县| 浦江县| 咸宁市| 大冶市| 吉木萨尔县| 乌审旗| 宁南县| 钟祥市| 尚义县| 西林县| 霍城县| 永嘉县| 永川市| 喀喇| 克东县| 双辽市| 水富县| 吉安县| 洛浦县| 潜山县| 沅陵县| 岑巩县| 元朗区| 大连市| 永丰县| 临邑县| 湘乡市| 武胜县| 沙洋县| 洞头县| 永清县| 塔河县| 运城市| 宜黄县| 漯河市| 新野县| 习水县| 德阳市| 仁寿县|